Bethany Alumni, Leading Medical Professionals
Present Future of Medicine Panel

BETHANY, W.Va. — Bethany will welcome four of the nation’s leading medical professionals and College alumni back to campus on April 19 for a public panel on the Future of Medicine. The event will be held in Bethany’s Mountainside Conference Center at 6:30 p.m. and will be streamed live online.

The College’s Future of Medicine discussion will feature Dr. Linda Donelle Lewis ’61, M.D., professor emerita of neurology at the Neurological Institute of New York; Dr. W. Blair Geho ‘60, M.D., Ph.D., SDG's founding president and chief executive officer, adjunct professor of investigative medicine and chief translational officer at the Case Western Reserve University School of Medicine; Dr. John Niederhuber ’60, M.D., CEO of Inova Translational Medicine Institute; and Dr. Timothy J. Vittorio ’89, M.S., M.D., Director of the Advanced Cardiac Therapeutics Program at St. Francis Hospital in Roslyn, N.Y.

Lewis will speak on “An MD Wears Many Hats.” Geho will focus on “Drug Inventions — Private Capital Fuels Innovation.” Niederhuber’s talk is titled “The Power of Genomics to Transform Medicine,” and Vittorio will present “Cardiac Failure — Transforming Failing Hearts.”

“We are delighted to welcome this talented group of alumni back to Bethany,” stated Bethany College President Scott D. Miller. “They have each played a key role in the development of medicine and medical policy in the nation, so to be able to bring them together and engage them in discussion on the future of medicine is an incredible opportunity for our students and community.”

Lewis, neurologist and Columbia University professor, graduated from Bethany College magna cum laude with a B.S. in 1961 and received her M.D. in 1965 from the West Virginia University School of Medicine. From 1965 to 1971 she was an intern in mixed medicine at the University of Wisconsin Hospital, an assistant resident and then a resident in internal medicine at St. Luke’s Hospital Center in New York, an assistant resident in neurology at Case Western Reserve University, and chief resident in neurology at Columbia-Presbyterian Medical Center.

Following her post-doctoral training, Lewis began her medical career as chief of neurology clinics at Presbyterian Hospital in New York, N.Y., where she later served as assistant neurologist, assistant attending neurologist and associate attending neurologist, and now serves as attending neurologist. She has also served as assistant attending neurologist at St. Luke’s Hospital Center and Harlem Hospital in New York and as associate attending neurologist at St. Luke’s-Roosevelt Hospital Center, where she is currently attending neurologist.

In addition to her professional appointments, Lewis has served in several academic roles since 1969 at the Columbia University College of Physicians and Surgeons, including senior associate dean for student affairs and clinical professor of neurology. In 1977 and 1992 she received the Distinguished Teacher Award, which is the highest teaching honor awarded by the College of Physicians and Surgeons. In 1991 she was named Outstanding Woman Doctor of the Year.

Lewis completed the Smith, Kline and French Foreign Medical Fellowship in India and was a visiting professor at Case Western Reserve University, West Virginia University, Ben Gurion University of Israel, American University of Beirut and the Medical School in Shiraz, Iran. In 1965 she received an award for outstanding scholastic achievement from the American Medical Women’s Association, and her biography was included in Who’s Who in American Universities in 1961, Who’s Who in American Women in 1975, The World Who’s Who in Women in 1977, Who’s Who in the East in 1979, and Who’s Who in the World in 1987.

Among her many activities, Lewis has been a member of the New York State Board for Professional Medical Conduct, the American Medical Association’s Council on Medical Education and the National Board of Medical Examiners Executive Board, and was a Founding Trustee for the Arnold P. Gold Foundation. She is a current member of the Bethany College Board of Trustees, where she has served as vice chair, chair of the Academic Affairs Committee, and a member of the Student Affairs Committee.

Geho, a native of Wellsburg, W.Va., graduated from Bethany College in 1960. He received his Ph.D. in pharmacology from Western Reserve University in 1964 and his M.D. from the same university in 1966. Following graduation, Geho was appointed to the School of Medicine faculty at Case Western Reserve University.

He moved to Cincinnati, Ohio, in 1967 and joined the Procter and Gamble Company (P&G). At P&G he led the development of the first bisphosphonate drug development culminating in FDA approvals for Didronel, the first drug to treat metabolic bone diseases, and Osteoscan, the first bone imaging product. In the 1980s Geho left P&G to found a series of biotechnology companies.

Geho is currently president and chief science officer for SDG, Inc., a Cleveland Clinic Equity Partner Company that is developing new insulin products, including an oral insulin that has received FDA approval to begin Phase 3 studies. Recently Geho accepted a position with the Case Western Reserve University School of Medicine as an adjunct professor of investigative medicine and its chief translational officer, responsible for overseeing the translation of new medical research discoveries into useful pharmaceutical products.

Niederhuber is a native of Steubenville, Ohio, and graduated from Bethany College in 1960. He was presented with an honorary doctorate from the College in 2007. He later graduated from the Ohio State University School of Medicine and trained in surgery at the University of Michigan. Niederhuber is former director of the National Cancer Institute (NCI) from 2006-2010, serves as executive vice president and CEO of the Inova Translational Medicine Institute.

As director of the National Cancer Institute, he began The Cancer Genome Atlas, an effort to identify the genomic changes in all major cancer types and subtypes. He also led the development of programs in cancer immunotherapy, nanobiology, systems biology, the physical sciences in cancer, investigations into the tumor microenvironment, cancer initiating cells, and subcellular imaging.

Niederhuber, known as a visionary leader in oncology, was elected vice president and president of the Society for Surgical Oncology and president of the Association of American Cancer Institutes. He has served as a member of C-Change and as a member of the CEO Roundtable on Cancer. He is also a member of the Institute of Medicine of the National Academy of Sciences.

Niederhuber is an adjunct investigator in the Laboratory of Tumor and Stem Cell Biology in NCI’s Center for Cancer Research. His current research focuses on factors in the tumor microenvironment, in particular on cancer activated fibroblasts that lead to increased malignancy.

His clinical focus as a surgeon has been on gastrointestinal cancer, hepatobiliary cancer, pancreatic cancer and breast cancer. Recognized for his pioneering work in hepatic artery infusion chemotherapy, he was the first to demonstrate the feasibility of totally implantable vascular access devices that changed the administration of systemic chemotherapy. He has received numerous awards and has authored or co-authored more than 200 publications. He has edited eight books, including the textbook “Abeloff’s Clinical Oncology.”

Niederhuber has served as director of the University of Wisconsin Comprehensive Cancer Center and as a professor of surgery and oncology at the University of Wisconsin School of Medicine. He has also chaired the Department of Surgery at Stanford University and held professorships at the Johns Hopkins University School of Medicine and at the University of Michigan.

Vittorio serves as program director of the Center for Advanced Cardiac Therapeutics at St. Francis Hospital in Roslyn, N.Y., and adjunct clinical associate professor of medicine at the New York Institute of Technology’s New York College of Osteopathic Medicine. He began his post-secondary education at Bethany College as a mathematics major. After graduating in 1989, he went on to receive an M.S. in biology from New York University in 1992 and his M.D. from Tel-Aviv University in Israel in 1996.

After graduating from Tel-Aviv University, Vittorio completed an internship in general surgery followed by an internship and residency in internal medicine at Albert Einstein College of Medicine/Montefiore Medical Center. Subsequently, he completed a Post-Doctoral Clinical/Research Heart Failure and Transplant Fellowship at the Columbia-Presbyterian Medical Center of Columbia University and was a Clinical Fellow in Cardiology at Columbia University/St. Luke’s-Roosevelt Hospital Center.

Following his training, Vittorio received his first hospital appointment as associate director of the Cardiac Care Unit and Cardiac Stepdown Unit at the NYU School of Medicine/Bellevue Hospital center. He has served as associate director of the Congestive Heart Failure Program at the Albert Einstein College of Medicine/Montefiore Medical Center and later served the same position at Mount Sinai School of Medicine/Mount Sinai Hospital Center.

In addition to his current academic appointment at the New York Institute of Technology, Vittorio has served as an Instructor of Medicine and later an assistant professor of Medicine at the New York University School of Medicine as well as an assistant professor of Medicine at the Albert Einstein College of Medicine and Mount Sinai School of Medicine. His research has been published in several scientific journals, including Circulation, the American Journal of Transplantation, Echocardiography, the European Journal of Heart Failure, the American Journal of Cardiology, the Journal of Heart and Lung Transplantation, the Journal of Cardiac Failure and Clinical Biochemistry.

To view the panel live online, visit and click on the “Online Bethany Broadcasting Network” icon on the right sidebar.

Bethany College is a small college of national distinction located on a picturesque and historic 1,300-acre campus in the Northern Panhandle of West Virginia. Founded in 1840, Bethany is the state’s oldest private college.